Published • loading... • Updated
Newborns Will Be Able to Access Immunization Against the Respiratory Syncicial Virus
Summary by resumendelaregion.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The Government of Alta Gracia reports that the application of Nirsevimab is available, an immunization aimed at preventing serious forms of infection with Respiratory Syncicial Virus, the main cause of bronchiolitis and one of the most frequent causes of pneumonia in infants during the first months of life. Immunization is targeted at newborns, children born from 1 January 2026, whose mothers have not received the respiratory Syncicial Virus vac…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
